We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+20.28%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$302M
AUM Growth
+$48.5M
Cap. Flow
-$22.8M
Cap. Flow %
-7.57%
Top 10 Hldgs %
35.65%
Holding
62
New
24
Increased
12
Reduced
14
Closed
11

Top Buys

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$13.3M
2
LH icon
Labcorp
LH
+$9.66M
3
HUM icon
Humana
HUM
+$6.55M
4
MDT icon
Medtronic
MDT
+$5.75M
5
HOLX
Hologic
HOLX
+$4.91M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$46M
2
BMY icon
Bristol-Myers Squibb
BMY
+$15.6M
3
UNH icon
UnitedHealth
UNH
+$10.6M
4
EHC icon
Encompass Health
EHC
+$7.73M
5
UHS icon
Universal Health Services
UHS
+$6.54M

Sector Composition

Rank Sector Weight
1 Healthcare 95.1%
2 Energy 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LHCG
26
DELISTED
LHC Group LLC
LHCG
$5.23M 1.73%
+30,000
New +$4.4M
AMED
27
DELISTED
Amedisys
AMED
$4.96M 1.64%
+25,000
New +$4.66M
NVRO
28
DELISTED
NEVRO CORP.
NVRO
$4.78M 1.58%
+40,000
New +$4.74M
MOH icon
29
Molina Healthcare
MOH
$10.6B
$4.63M 1.53%
+26,000
New +$4.43M
ZBH icon
30
Zimmer Biomet
ZBH
$18.3B
$4.36M 1.44%
25,750
+5,150
+25% +$593K
BDX icon
31
Becton Dickinson
BDX
$49.2B
$4.25M 1.41%
+18,206
New +$4.39M
JNJ icon
32
Johnson & Johnson
JNJ
$628B
$4.22M 1.4%
+30,000
New +$4.37M
TMO icon
33
Thermo Fisher Scientific
TMO
$223B
$4.04M 1.34%
106,069
+6,069
+6% +$2.03M
PPD
34
DELISTED
PPD, Inc. Common Stock
PPD
$4.02M 1.33%
+150,000
New +$3.75M
BIIB icon
35
Biogen
BIIB
$30.5B
$4.01M 1.33%
15,000
-5,000
-25% -$1.5M
GILD icon
36
Gilead Sciences
GILD
$170B
$3.85M 1.27%
+50,000
New +$3.83M
THC icon
37
Tenet Healthcare
THC
$21.3B
$3.84M 1.27%
25,000
+7,500
+43% +$148K
BMY icon
38
Bristol-Myers Squibb
BMY
$130B
$3.81M 1.26%
60,000
-260,000
-81% -$15.6M
ILMN icon
39
Illumina
ILMN
$28.9B
$3.7M 1.23%
+10,280
New +$3.31M
TEVA icon
40
Teva Pharmaceuticals
TEVA
$42.7B
$3.39M 1.12%
+275,000
New +$3.11M
AVTR icon
41
Avantor
AVTR
$9.33B
$2.98M 0.99%
+175,000
New +$2.85M
AMRX icon
42
Amneal Pharmaceuticals
AMRX
$6.02B
$2.86M 0.95%
+600,000
New +$2.47M
BNTX icon
43
BioNTech
BNTX
$23.4B
$2.67M 0.88%
+40,000
New +$2M
ADPT icon
44
Adaptive Biotechnologies
ADPT
$3.97B
$2.42M 0.8%
+50,000
New +$1.82M
ACH
45
Accendra Health
ACH
$96.1M
$2.28M 0.75%
+298,700
New +$2.19M
CRSP icon
46
CRISPR Therapeutics
CRSP
$5.2B
$2.21M 0.73%
+30,000
New +$1.75M
AGIO icon
47
Agios Pharmaceuticals
AGIO
$2.03B
$2.14M 0.71%
+40,000
New +$1.85M
BLUE
48
DELISTED
bluebird bio
BLUE
$2.14M 0.71%
+2,702
New +$2.04M
ABT icon
49
Abbott
ABT
$192B
$1.93M 0.64%
25,000
-40,000
-62% -$3.62M
CNST
50
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$1.8M 0.6%
+60,000
New +$2.16M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q2 2020 Portfolio in Review

As of Q2 2020, Sivik Global Healthcare held 62 positions worth $302M, up 19% from $253M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sivik Global Healthcare withdrew a net $22.8M in Q2 2020, closing 11 positions and reducing 14 holdings. Its most notable exit was UnitedHealth, an estimated $10.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 98% a quarter earlier, followed by Energy.

Against the trend, Sivik Global Healthcare opened a new position in Quest Diagnostics worth $14.2M.

  • Sivik Global Healthcare's largest Q2 2020 buy was Quest Diagnostics: 125,000 shares worth $14.2M.
  • Sivik Global Healthcare added most to Humana in Q2 2020, an estimated $6.55M increase.
  • Sivik Global Healthcare's biggest Q2 2020 reduction was Intuitive Surgical, cutting an estimated $46M.
  • Sivik Global Healthcare fully exited UnitedHealth in Q2 2020, selling an estimated $10.6M.
  • Sivik Global Healthcare's ten largest holdings make up 36% of its $302M portfolio in Q2 2020.
  • Sivik Global Healthcare opened 24 new positions and closed 11 in Q2 2020.
  • Sivik Global Healthcare's portfolio value rose 19% quarter-over-quarter to $302M.

Based on Sivik Global Healthcare's 13F filing for Q2 2020, filed 14 Aug 2020.